DYNALABS LLC Named One of Inc. 5000 Fastest-Growing Private Companies in 2017

August 16, 2017

ST. LOUIS – For the fourth time, DYNALABS LLC made the 2017 Inc. 5000 list of the fastest-growing private companies in America. Out of nearly 7 million private companies moving the economy forward every day, only a small fraction demonstrate remarkable and consistent high growth.

DYNALABS LLC is proud to have made this list again. DYNALABS continues to grow every day and impacts the economy and patients’ safety and lives.  It conducts all business with its guiding principles of patient safety, affordable healthcare, and business success on our mind.

Its state-of-the-art facilities have come a long way since 2004, and the facilities are getting another $1.3 million upgrade this fall. The testing and consultation services are expanding year by year as well.

The companies that make this list are the superheroes of the U.S. economy. They wield such powers as strategy, service, and innovation.  This year, companies that made the list, on average, have grown six-fold since 2013. Making the list four times is an extraordinary accomplishment, especially because every year it gets tougher to make the list as the starting base grows.  Only a fraction of companies make the list more than once, and a mere one in ten have made the list four times.

Read the article:  https://www.inc.com/inc5000

About DYNALABS

DYNALABS LLC is a privately held, internationally known, quality assurance company that provides analytical testing services, products and consulting to the compounding pharmaceutical industry. Its clients include hospitals and 503A compounding pharmacies, 503B outsourcing facilities and chemical re-packagers.  DYNALABS LLC is in a 33,000-square foot, state-of-the-art facility located in downtown St.  Louis, Missouri, and currently employs over 90 full-time, part-time and contracted professionals.  DYNALABS LLC is registered with the FDA and is licensed by the Drug Enforcement Agency and the Missouri Bureau of Narcotics and Dangerous Drugs.